Skip to main content

Table 4 Amino acid sequences of proposed peptides, their predicted binding affinity values (ΔG—kcalmol−1) and dissociation constant (Kd) with individual catalytic domains of the different proteins studied

From: Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design

Protein

Peptide

1

2

3

4

5

ΔG

Kd (M)

ΔG

Kd (M)

ΔG

Kd (M)

ΔG

Kd (M)

ΔG

Kd (M)

FP-2

− 11.8

2.2E−09

− 11.2

8.4E−09

− 8.1

1.2E−06

− 9

2.7E−07

− 11.4

4.4E−09

FP-3

− 12.2

1.2E−09

− 10.5

2.0E−08

− 9.6

9.4E−08

− 9.7

7.8E−08

− 12.3

8.8E−10

VP-2

− 11.0

8.3E−09

− 10.1

3.8E−08

− 12.3

8.8E−10

− 9.0

2.7E−07

− 10.9

1.1E−08

VP-3

− 11.7

2.7E−09

− 11.0

8.3E−09

− 9.9

5.7E−08

− 9.2

1.7E−07

− 11.8

2.1E−09

KP-2

− 12.7

4.7E−10

− 11.8

2.1E−09

− 6.7

1.3E−05

− 8.1

1.2E−06

− 10.6

1.8E−08

KP-3

− 11.8

2.1E−09

− 12.7

5.2E−10

− 9.3

1.4E−07

− 9.2

1.9E−07

− 12.7

5.2E−10

BP-2

− 11.5

3.7E−09

− 12.2

1.2E−09

− 10.9

9.9E−09

− 7.9

1.7E−06

− 11.7

2.7E−09

CP-2

− 11.9

2.2E−09

− 11.7

2.7E−09

− 8.7

3.9E−07

− 8.3

1.1E−07

− 12.7

4.7E−10

YP-2

− 11.7

2.7E−09

− 14.3

5.5E−11

− 12.4

7.9E−10

− 10.4

2.5E−08

− 9.3

1.5E−07

Cat-K

− 13.9

6.3E−11

− 11.5

3.5E−09

− 11.9

2.0E−09

− 11.4

4.2E−09

− 8.3

1.1E−07

Cat-L

− 12.2

1.0E−09

− 11.8

5.1E−09

− 12.3

9.7E−10

− 10.2

3.5E−08

− 8.7

9.2E−07

Cat-S

− 10.4

2.4E−09

− 11.5

3.5E−09

− 12.4

7.7E−10

− 9.9

5.2E−08

− 8.6

4.8E−07

  1. Peptide 1NRFGDLSFEEFKKKYLNLKLFD, 2LTYHEFKNKYLSLRSSK, 3MTFEEFKQKYLTLKSKD, 4EFKKKYLTLK, 5EFKKKYLTLKSKD